Retirement Solution’s Invesco BulletShares 2023 High Yield Corporate Bond ETF BSJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-94,271
Closed -$2.22M 47
2023
Q3
$2.22M Sell
94,271
-5,488
-6% -$129K 0.73% 17
2023
Q2
$2.35M Sell
99,759
-195
-0.2% -$4.59K 0.76% 16
2023
Q1
$2.35M Sell
99,954
-1,727
-2% -$40.6K 0.83% 15
2022
Q4
$2.37M Sell
101,681
-20,756
-17% -$483K 1.3% 6
2022
Q3
$2.79M Buy
122,437
+3,159
+3% +$73.9K 1.5% 7
2022
Q2
$2.74M Sell
119,278
-7,048
-6% -$168K 1.48% 7
2022
Q1
$3.1M Buy
126,326
+8,288
+7% +$205K 1.37% 6
2021
Q4
$2.98M Buy
118,038
+10,905
+10% +$275K 1.28% 6
2021
Q3
$2.71M Buy
107,133
+5,844
+6% +$148K 1.25% 10
2021
Q2
$2.58M Buy
101,289
+1,018
+1% +$25.8K 1.23% 10
2021
Q1
$2.54M Buy
100,271
+6,360
+7% +$161K 1.53% 10
2020
Q4
$2.38M Buy
+93,911
New +$2.35M 1.57% 10

Other funds holding BSJN

Retirement Solution's BSJN Position: Q4 2023 in Review

Retirement Solution sold out of Invesco BulletShares 2023 High Yield Corporate Bond ETF (BSJN) in Q4 2023, closing a stake of 94,271 shares — an estimated $2.22M sold.

Retirement Solution first reported a position in BSJN in Q4 2020 and held it in 12 quarters. The position peaked at $3.1M in Q1 2022. 4 funds tracked by Wall St. Rank hold BSJN as of Q4 2023.

  • Retirement Solution reported no remaining Invesco BulletShares 2023 High Yield Corporate Bond ETF position as of Q4 2023 after selling out during the quarter.
  • Retirement Solution sold 94,271 Invesco BulletShares 2023 High Yield Corporate Bond ETF shares in Q4 2023, an estimated $2.22M.
  • Retirement Solution first reported a position in Invesco BulletShares 2023 High Yield Corporate Bond ETF in Q4 2020 and held it in 12 quarters.
  • Retirement Solution's Invesco BulletShares 2023 High Yield Corporate Bond ETF position peaked at $3.1M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Invesco BulletShares 2023 High Yield Corporate Bond ETF as of Q4 2023.

Based on Retirement Solution's 13F filing for Q4 2023, filed 2 Feb 2024.